Table 1 Patients’ characteristics summary
Characteristics |  | Patients (n = 114) | |
|---|---|---|---|
Age | Â | 63 | (29,83) |
Sex | Male | 81 | 71.1 |
Female | 33 | 28.9 | |
KRAS mutation | Mutated | 35 | 30.7 |
Wild type | 79 | 69.3 | |
BRAF mutation | Mutated | 3 | 2.6 |
Wild type | 111 | 97.4 | |
Tumor side | Left | 89 | 78.1 |
Right | 25 | 21.9 | |
Chemotherapy | Neoadjuvant | 78 | 68.4 |
adjuvant | 30 | 26.3 | |
None | 6 | 5.2 | |
Type of Chemotherapy | FOLFOX | 47 | 60 |
FOLFOX anti VEGF | 18 | 23 | |
FOLFOX anti EGFR | 11 | 14 | |
Other | 2 | 3 | |
Other | 45 | 57.7 | |